Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Funding
Sign In Sign Up
Night Mode
Biosimilar Uptake: What Drives Adoption of Herceptin Alternatives?
The availability of biosimilars doesn't automatically translate to adoption. Despite regulatory approval and price advantages, uptake of Herceptin biosimilars varies widely across markets, reflecting complex interactions between payer policies, clinician preferences, patient awareness, and healthcare system structures. Understanding what drives adoption is essential for manufacturers,...
0 Comments ·0 Shares ·26 Views ·0 Reviews
Please log in to like, share and comment!